CARLA RANGEL: Open Payments
NPI 1548816556 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 11 payments from 10 companies in 2025. Trend: 2023 $934 · 2024 $1,372 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $122 |
| BeOne Medicines USA, Inc. | 1 | $114 |
| Ipsen Biopharmaceuticals, Inc | 1 | $84 |
| Tempus AI, Inc | 1 | $56 |
| ABBVIE INC. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| ARRAY BIOPHARMA INC | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $22 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $19 |
Products named: ADCETRIS, RYBREVANT, BRUKINSA, Onivyde, XT CDX, LYNOZYFIC, EPKINLY, BRAFTOVI.
Industry payments across TX — which companies pay providers there.
